Holen Sie sich die Stockscreener-App
28.42
1,515%
26.66
Second Sight Medical Products, Aktie (EYES) Neueste Nachrichten
Second Sight Medical Products Inc (VANIW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Second Sight Medical Products Inc (VANIW) Peer Comparison – Compare with Others - Value Research
Second Sight Medical Products Inc. Warrants (EYESW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Second Sight Medical Products Inc. Warrants (EYESW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Second Sight Medical Products Inc. Warrants (EYESW) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Second Sight Medical Products Inc. (EYES) Peer Comparison – Compare with Others - Value Research
Second Sight Medical Products Inc (VANIW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Second Sight Medical Products Inc (VANIW) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
EU Clears PRIMA Retinal Chip for Commercial Sale After AMD Patient Reads 300-Page Novel - The Eastern Herald
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream - GlobeNewswire Inc.
ClearOne skyrockets from neurotech pivot, merger with Cortigent - Mugglehead Investment Magazine
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - markets.businessinsider.com
Vivani Medical allows Novo Nordisk to evaluate NPM-139 - scanx.trade
ClearOne Merging With Cortigent - Pulse 2.0
Vivani to sell neurotech subsidiary Cortigent to ClearOne - MassDevice
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical - Business Wire
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker - GlobeNewswire
Vivani Medical appoints August Moretti to board as Dr. Dean Baker retires - scanx.trade
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention - markets.businessinsider.com
European Union Retinal Implant Electrode ArraysMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
World Auditory Brainstem ImplantsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Visual Prosthesis Market Size, Share, Growth, Forecast, 2034 - Straits Research
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026 - markets.businessinsider.com
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
Medical Bionic Implant and Artificial Organs Price in the European UnionMarket Insights - IndexBox
Stock List: Research Stocks from Around the World - GuruFocus
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire
Single semaglutide implant showed >20% weight loss for a year - Stock Titan
Promising Six-Year Early Feasibility Study Results Released for the Orion System - Medical Product Outsourcing
Electroceuticals Market Size, Share & Growth Report, 2034 - Market Data Forecast
'Bionic Eye' Helps Man See After Decade of Impaired VisionABC News - ABC News - Breaking News, Latest News and Videos
Don’t Let Elon Musk Implant a Device in Your Skull - Home ❧ Current Affairs
Vivani Subsidiary Cortigent Presents Promising 6-Year Early - GlobeNewswire
Vivani Subsidiary Cortigent to Present Orion System’s - GlobeNewswire
Artificial Eye Market Size, Share, Growth | CAGR of 7.8% - Market.us
Study Links Rod Cell Evolution to Dinosaur Extinction Event - 동아사이언스
Robert Greenberg Net WorthInsider Trades and Bio as of Apr 22, 2026 - Benzinga
Science Corp.'s Prima implant enables blind patients to read - bioworld.com
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewswire
Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders - GlobeNewswire
Ocular Implants Market Size, Demand & Revenue Statistics by 2033 - Straits Research
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer - GlobeNewswire
EYES Stock Price, News & Analysis - Stock Titan
Vivani to spin off neurostimulation business - MedTech Dive
Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business - Business Wire
Sight Care – Study Findings, Reviews, Ingredients and Where to Buy It - GlobeNewswire
Cortigent, Inc IPOs Tomorrow, Here's What You Need To Know - Sahm
Second Sight Medical’s Argus II Recognized by Popular Science Magazine - Medical Product Outsourcing
Bionic Eye Market to Reach US$ 524 Million by 2032 - Market.us Media
Treatment and technology: The future of retina care - Ophthalmology Times Europe
Neuralink’s Blindsight implant labelled 'breakthrough' - Information Age | ACS
The future of retina care - Modern Retina
Second Sight Medical Products (NASDAQ: EYES)Share Price - intelligentinvestor.com.au
Bionic Eye Gets a New Lease on Life - IEEE Spectrum
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant - TradingView
Neuralink, between Benefits, Risks and Ethics - Kompas.id
Bionic Breakthroughs: Merging Humans with Technology for a Better Future - Vocal
Lab team sets sight on new artificial retina - Lawrence Livermore National Laboratory (.gov)
The Argus-II Retinal Prosthesis Implantation; From the Global to Local Successful Experience - Frontiers
Patient-specific computational models of retinal prostheses - Nature
Is Second Sight Closing up Shop? - Medical Device and Diagnostic industry
Proteus Digital Health Files for Bankruptcy - Medical Device and Diagnostic industry
Bionic Eye Market Size To Reach USD 1,609.38 Million By 2035 - Precedence Research
Second Sight's Argus II Bionic Eye Approved for Medicare Codes - Medical Device and Diagnostic industry
Second Sight Merges with NPM to Become Vivani - Medical Device and Diagnostic industry
Second Sight Reveals Two-Year Results from Orion Study - Medical Device and Diagnostic industry
Life After Bankruptcy: Reva Returns with Funding Raise - Medical Device and Diagnostic industry
Second Sight Wants to Treat Most Blind People with New Bionic Eye - Medical Device and Diagnostic industry
Making Geordi's VISOR a Reality - Medical Device and Diagnostic industry
Second Sight Is in Merger Talks … Again - Medical Device and Diagnostic industry
1.18%
1.44%
Kapitalisierung:
|
Volumen (24h):